期刊文献+

超抗原SEB的免疫抑制作用及其机制的初步研究 被引量:1

Immunity suppressive effect and possible mechanism of SEB as a superantigen
下载PDF
导出
摘要 目的研究金黄色葡萄球菌肠毒素SEB作为超抗原的免疫抑制性作用及其可能机制。方法BALB/c小鼠注射金黄色葡萄球菌B型肠毒素(staphylococcal enterotoxin B,SEB),分离其脾脏细胞,研究SEB刺激小鼠脾细胞产生的反应,并通过FCM检测脾细胞表面CD4和CD25分子的表达情况,探讨其内在机制。结果FCM表明与生理盐水对照组相比,注射过SEB后的BALB/c小鼠的脾脏细胞中CD4和CD25双阳性细胞比例增加,提示SEB的免疫抑制作用可能和其诱导调节性T细胞有关。结论SEB可以在小鼠体内有效诱发具有抑制活性的调节性细胞,这可能是SEB在动物体内诱发免疫低反应的机制之一。 Objective To study the immunity suppressive effect of the staphylococcal enterotoxin as a super-antigen and investigate its mechanism. Methods BALB/c mice aged 8-12 weeks were randomly assigned to receive 0.2 ml injection of 50 μg/ml staphylococcal enterotoxin B (SEB) ( n = 20) or 0. 2 ml physiological saline (n =20). One day later, all mice were sacrifice to collect the splenoeytes which were employed to detect the expression of TGF-[31 and to eountthe cells expressing CD4 and CD25 by flow eytometry (FCM). Results FMC showed that a remarkable increase of cells that expressed CD4 and CD25 in the SEB-primed splenoeytes as compared with the saline primed splenocytes. Conclusion SEB, which is used as a superantigen in vivo, can induce the regulatory cells bearing suppressive activity. This may be partial mechanism of SEB-induced hyporesponsiveness.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第22期2239-2241,共3页 Journal of Third Military Medical University
关键词 超抗原 SEB 免疫抑制 superantigen SEB immunity suppression
  • 相关文献

参考文献14

  • 1Alouf J E, Muller Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects[J].Int J Med Microbiol, 2004, 292(7-8): 429-440.
  • 2Perkins D L, Listman J A, Wang Y, et al. Differential expression of activation markers during tolerance induction by superantigens in T-cell receptor (beta-chain) transgenic mice[J]. Cell Immunol, 1994, 156(2): 310-321.
  • 3Aroeira L S, Moreno M C, Martinez C. In vivo activation of T-cell induction into the primed phenotype and programmed cell death by staphylococcal enterotoxin B[J]. Scand J Immunol, 1996, 43(5): 545-550.
  • 4Baker M D, Acharya K R. Superantigens: structure function relationships[J]. Int J Med Microbiol, 2004, 293(7-8): 529-537.
  • 5Petersson K, Forsberg G, Walse B. Interplay between superantigens and immunoreceptors[J]. Scand J Immunol, 2004, 59(4): 345-355.
  • 6Miller C, Ragheb J A, Schwartz R H. Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo[J]. Exp Med, 1999, 190(1): 53-64.
  • 7Jonuleit H, Schmitt E, Kakirman H, et al. Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells[J]. J Exp Med., 2002, 196(2): 255-260.
  • 8Papageorgiou A C, Acharya K R. Microbial superantigens: from structure to function[J]. Trends Microbiol, 2000, 8(8): 369-375.
  • 9Wang Z Q, Orlikowsky T, Dudhane A, et al. Staphylococcal enterotoxin B-induced T-cell anergy is mediated by regulatory T cells[J]. Immunology, 1998, 94(3): 331-339.
  • 10Thornton A M, Shevach E M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific[J]. J Immunol, 2000, 164(1): 183-190.

同被引文献14

  • 1Wang ZO,OrIikowsky T,Dudhane A. Staphylococcal enterotoxin B-induced T-cell anergy is mediated by regulatory T cells[J].{H}IMMUNOLOGY,1998.331-339.
  • 2Thornton AM,Shevach EM. Suppressor effector function of CD4CD25+immunoregulatory T cells is antigen nonspecific[J].{H}Journal of Immunology,2000.183-190.
  • 3Bennett CL,Ochs HD. IPEX is a unigue X-linked syndrome characterized by immune dysfunction,polyendocrinopathy,enteropathy,and a variety of autoimmune phenomena[J].{H}Current Opinion in Pediatrics,2001.533-538.
  • 4Bean AG,Freiberg RA,Andrade S. Interleukin 10 protect mice against staphylococcal enterotoxin B-induced lethaI shock[J].{H}Infection and Immunity,1993.4937-4939.
  • 5Hara M,Kingsley CI,Niimi M. IL-10 is required for regulatory T cells to mediate tolerance to al oantigens in vivo[J].{H}Journal of Immunology,2002.1080-1086.
  • 6Porto G,Giordano RJ,Marti LC. Identification of novel immunoregulatory molecules in human thymic regulatory CD4+CD25+T cells by phage display[J].PLoS One,2011.e21702.
  • 7Kingsley CI,Karim M,Bushell AR. CD25+CD4+regulatory T cells prevent graft rejection:CTLA-4 and IL-10-dependent immunoregulation of alloresponses[J].{H}Journal of Immunology,2002.1080-1086.
  • 8Thornton AM,Korty PE,Tran DQ. Expression of Helios,an Ikaros transcription factor family member,differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells[J].{H}Journal of Immunology,2010.3433-3441.
  • 9Jeffery LE,Burke F,Mura M. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3[J].{H}Journal of Immunology,2009.5458-5467.
  • 10Graca L,Cobbold SP,Waldmann H. Identification of regulatory T cells in tolerated allografts[J].{H}Journal of Experimental Medicine,2002.1641-1646.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部